GlassScriptPhysician profile
Julie Paul
NPI 1235533837
$3,522.27
in general payments reported to CMS, 2019-2025
33 companies · $984 in 2025
The $984 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $715 · 2023: $816 · 2024: $690 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.74 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $439.00 | 2022-2025 | |
| Organon LLC | $273.89 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $217.94 | 2021-2025 | Slynd |
| Pfizer INC. | $201.26 | 2021-2024 | |
| Astellas Pharma US INC | $130.29 | 2024-2025 | Veozah |
| Millicent US INC | $128.11 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Hologic Sales and Service, LLC | $125.96 | 2021-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima, Acessa Provu System |
| Shield Therapeutics INC | $122.73 | 2023-2025 | Accrufer |
| Baxter Healthcare | $121.28 | 2024-2025 | Perclot, Tisseel |
| Therapeuticsmd, INC. | $120.48 | 2021-2022 | |
| Myriad Women'S Health, INC. | $98.42 | 2023 | |
| Axonics, INC. | $76.61 | 2023 | Axonics, Bulkamid |
| Biogen, INC. | $70.25 | 2025 | Zurzuvae |
| Scynexis, INC. | $64.45 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $63.26 | 2023-2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $59.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.70 | 2021-2024 | |
| Becton, Dickinson and Company | $57.23 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $54.80 | 2025 | Voquezna |
| Novo Nordisk INC | $50.18 | 2023-2024 | |
| Agile Therapeutics, INC. | $49.83 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $44.48 | 2024-2025 | |
| Coopersurgical, INC. | $32.62 | 2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $25.51 | 2022 | |
| Boston Scientific Corporation | $24.15 | 2025 | Bulkamid |
| Gynesonics, INC. | $23.98 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $20.46 | 2023 | Balcoltra |
| Olympus America INC. | $19.95 | 2025 | Olympus |
| Medicem INC. | $19.65 | 2021 | |
| Sanofi Pasteur INC. | $19.64 | 2024 | |
| Exact Sciences Corporation | $17.91 | 2025 | The Cologuard Plus Collection Kit |
| Molnlycke Health Care US, LLC | $16.06 | 2024 | Mepilex Border Post-Op Ag, Avance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.